摘要
目的:分析观察卡贝缩宫素联合前列素氨丁三醇在预防产后出血中的临床应用效果.方法:本研究选2020年8月2021年8月接诊孕产妇86例.依据孕产妇就诊顺序编号单双数分为对照组(n=43)和观察组(n=43).对照组孕产妇胎儿娩出后使用卡贝缩宫素,观察组在对照组基础上加用卡前列素氨丁三醇.对比分析两组孕产妇治疗后各项指标变化.结果:两组产妇术中、术后2h内及术后2h后出血量比较,观察组各个时间指标出血量均少于对照组,差异具有统计学意义(P < 0.05);产前两组产妇血红蛋白浓度无差异,产后24h后,观察组血
Abstract
Objective To analyze and observe the effect of clinical application of cabesin combined with prostaglandin tromethamine in preventing postpartum hemorrhage .Methods: 86 pregnant women were selected from August 2020 to August 2021 in this study.The pregnant women were divided into control group (n=43) and observation group (n=43) according to the single or even numbers of their visit order.After the delivery of the fetus, the pregnant women in the control group were treated with carboprost oxytocin, while the observation group was treated with carboprost tromethamine on the basis of the control group.Comparative analysis of the two groups of pregnant women after treatment of various indicators. Results: Compared the bleeding volume of the two groups during operation, within 2 hours after operation and 2 hours after operation, the bleeding volume of each time index in the observation group was less than that in the control group, and the difference was statistically significant (P<0.05); There was no difference in the concentration of hemoglobin between the two groups before delivery.After 24 hours after delivery, the concentration of hemoglobin in the observation group was higher, and the proportion of hemoglobin concentration decreasing by more than 10% and the decreasing value of hemoglobin concentration were better than those in the control group.The data difference analysis was statistically significant (P<0.05); The incidence of adverse reactions in the control group was higher than that in the observation group, but there was no significant difference between the two groups (P>0.05).Conclusion: Carboxytocin combined with prostaglandin tromethamine has a positive effect on the prevention of postpartum hemorrhage, can effectively reduce the loss of hemoglobin, effectively reduce the amount of bleeding, and will not increase the risk of drug use.